-
priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient engagement, and
-
stress fields); design computational pipelines that integrate image-based anatomy, blood flow physics, and uncertainty quantification; validate the developed methods on retrospective multi-center clinical
-
, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient engagement, and the ethical, regulatory and health-economic aspects of therapy development. The network
-
biology, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient engagement, and ethical, regulatory and health-economic aspects of therapy development
-
countries (HIC). The airm of this PhD project is to understand how E. coli colonization contributes tot he risk of diarrheal disease and infections with AMR and use this knowledge to design interventions
-
invasive and non-invasive quantitative brain PET studies; designing model-independent kinetic analysis methods for dynamic PET imaging; developing connectivity analysis techniques for brain LAFOV PET/CT data
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical
-
treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient
-
treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical